finasteride has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ateya, AI; Ezz, MA; Fehaid, A; Marghani, BH; Saleh, RM | 1 |
| Angrimani, DSR; Brito, MM; Francischini, MCP; Vannucchi, CI | 1 |
| Cagnon, VH; Hetzl, AC; Kido, LA; Montico, F | 1 |
| Armenakas, NA; Basillote, JB; Fracchia, JA; Hochberg, DA; Pareek, G; Shevchuk, M; Vasovic, L | 1 |
| Kaya, C; Ozyurek, M; Turkeri, LN | 1 |
| Guzel, O; Han, O; Memis, A; Ozdal, OL; Ozden, C; Seckin, S | 1 |
2 trial(s) available for finasteride and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients.
Topics: Aged; Antigens, CD34; Endothelial Growth Factors; Finasteride; Hematuria; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Microcirculation; Neovascularization, Pathologic; Prospective Studies; Prostate; Prostatic Hyperplasia; Urethra; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
Topics: Aged; Enzyme Inhibitors; Finasteride; Hematuria; Humans; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Prostate; Prostatic Hyperplasia | 2008 |
4 other study(ies) available for finasteride and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats.
Topics: Animals; Antioxidants; Apoptosis; Dihydrotestosterone; Drug Delivery Systems; Finasteride; Hyperplasia; Male; Metal Nanoparticles; Neovascularization, Pathologic; Phototherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Silver; Surface Plasmon Resonance; Testosterone; Testosterone Propionate | 2022 |
Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy.
Topics: Animals; Dog Diseases; Dogs; Finasteride; Gene Expression Regulation; Hemodynamics; Hormones; Male; Neovascularization, Pathologic; Orchiectomy; Prostatic Hyperplasia; Ultrasonography, Doppler; Vascular Endothelial Growth Factor A | 2020 |
Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Angiogenesis Inhibitors; Animals; Blotting, Western; Cyclohexanes; Disease Models, Animal; Endostatins; Fibroblast Growth Factor 2; Finasteride; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Indoles; Male; Mice; Mice, Transgenic; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Prostatic Neoplasms; Pyrroles; Sesquiterpenes; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.
Topics: Androgen Antagonists; Anilides; Animals; Castration; Dissection; Enzyme Inhibitors; Finasteride; Immunohistochemistry; Male; Neovascularization, Pathologic; Nitriles; Prostate; Rats; Rats, Sprague-Dawley; Tosyl Compounds | 2005 |